Google (GOOGL.US)-backed AI pharmaceutical company Isomorphic Labs starts a new round of fundraising: received $2.1 billions just five months ago, this round aims for a $50 billions valuation.
智通财经2026/10/08 06:36According to sources cited by Zhitong Finance APP, Isomorphic Labs, an AI drug development startup spun out from Google DeepMind, a subsidiary of Alphabet (GOOGL.US), is in preliminary talks for a new round of financing with a target valuation of at least $40 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot gold breaks through $4130/ounce, up 0.47% intraday
Spot gold has just surpassed the $4,130.00 per ounce mark, with the latest price at $4,130.19 per ounce, up 0.47% on the day; COMEX gold futures main contract is now quoted at $4,155.00 per ounce, up 0.35% on the day.
U.S. stocks fluctuation | Optical communication concept stocks generally fall; Applied Optoelectronics (AAOI.US) drops over 5%
According to Zhitong Finance APP, on Thursday, fiber optic communication concept stocks broadly declined. Applied Optoelectronics (AAOI.US) fell over 5%, Coherent (COHR.US) dropped 4%, POET Technologies (POET.US) and Corning (GLW.US) both declined more than 3%, Marvell Technology (MRVL.US) and Nokia (NOK.US) slid nearly 3%, Lumentum (LITE.US) was down over 2%, and Credo Technology (CRDO.US) fell more than 1%.
【US Stock Movement】Mexican Grill surged on October 8: plans to launch group meals and Halloween marketing
Crypto prices
More
